Bilcare Ltd.

Web: bilcare-group.com NSE: BI BSE: 526853 SECTOR: Healthcare - Healthcare Services

60 1(-1%)

Volume

34k as on 30, Jun

Open

76

High

78

Low

68

Close

61

VWAP

61

52 Week High

75

52 Week Low

52

Viand Research Rating
Quality Score

36/100

Growth Score

6/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

141

No. of Shares

2.35

P/E

-25.13

P/B

0.31

Face Value

10

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

-1.25

ROCE

-

Profit Growth

-

Listing Date

Promoter Holding

30.01%

FII Holding

0.04%

DII Holding

-

Price Chart
Price Performance
1 Week9%
1 Month0%
3 Months2%
6 Months2%
1 Year2%
YTD2%
Moving Average
5 Day SMA58
10 Day SMA58
20 Day SMA60
30 Day SMA61
50 Day SMA0
61 Day SMA0
80 Day SMA0
200 Day SMA0
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 359575859
Resistance 258575758
Resistance 157565757
Pivot Point56565656
Support 155565555
Support 254565554
Support 353565453
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1SUNPHARMA4,68,07519510%4%19%16%3757.70.0711509
2DIVISLAB1,93,36772842%9%22%11%6957.702568
3TORNTPHARM1,71,22150590%13%25%42%7257.71.792138
4APOLLOHOSP1,27,07788380%6%31%21%5857.70.92003
5CIPLA1,13,28414022%0%3%4%2257.70.023862
6ZYDUSLIFE1,11,09211143%4%27%17%2057.70.465124
7LUPIN1,09,48023943%3%11%25%2357.70.295355
8MAXHEALTH1,05,42510832%1%8%14%057.70.321442
9MANKIND1,05,07025440%0%18%3%4957.70.391938
10DRREDDY97,17911654%8%3%5%2057.70.24158
Load More
Shareholding Pattern (%)
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021
Promoters(0.01) 30.01%(0.01) 30.01%(0.01) 30.01%(0.01) 30.01%(0.01) 30.01%(0.01) 30.01%(0.01) 30.01%(0.01) 30.01%(0.01) 30.01%(0.01) 30.01%(0.01) 30.01%(0.01) 30.01%(0.01) 30.01%(0.01) 30.01%(0.01) 30.01%(0.01) 30.01%(0.01) 30.01%(0.01) 30.01%
FIIs(0.01) 0.04%(0.01) 0.04%(0.01) 0.04%(0.01) 0.04%(0.01) 0.04%(0.01) 0.04%(0.01) 0.04%(0.01) 0.04%(0.01) 0.04%(0.01) 0.04%(0.01) 0.04%(0.01) 0.04%(0.01) 0.04%(0.01) 0.04%(0.01) 0.04%(0.01) 0.04%(0.01) 0.04%(0.01) 0.04%
Public69.95%69.95%69.94%69.95%69.95%69.95%69.95%69.95%69.95%69.95%69.94%69.95%69.95%69.95%69.94%69.94%69.95%69.94%
No. of Shareholders15,82416,06816,51317,04717,58618,49618,24118,78319,11619,18119,87521,69122,32223,41923,23623,15822,32221,928
Quarterly Results
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Sales187.66181.32178.2186.36194.03198.13201.74194.14200.07174.94189.92182.25233.59246254248.13255.69208204
Sales Growth % (YoY)-3.3%-8.5%-11.7%-4%-3%13.3%6.2%6.5%-14.4%-28.8%-25.2%-26.6%-8.6%18.3%24.8%39.6%45.5%32.8%34.2%
Sales Growth % (QoQ)3.5%1.8%-4.4%-4%-2.1%-1.8%3.9%-3%14.4%-7.9%4.2%-22%-5%-3.1%2.4%-3%22.9%2%-
Expenses170.73168.31174.78175.29186.35187.47194.09175.2208.33157.69173.22168.79219.16234240232.26236.93194188
Operating Profit16.9313.013.4211.077.6810.667.6518.94-8.2617.2516.713.4614.43121415.8718.761316
OPM %9.027.181.925.943.965.383.799.76-4.139.868.797.396.18566.47.3468
Other Income12.463.344.326.0821.16-6.47-6.023.748.823.760.562.75231.29-6102.685.13034
Interest17.6917.0419.0618.5518.6819.4823.6820.8522.5920.5419.661911.38161615.8216.951618
Depreciation4.785.0112.2311.564.6611.7411.0411.5213.410.5710.4810.59.31099.439.45109
Profit before tax6.92-5.7-23.55-12.965.5-27.03-33.09-9.69-35.43-10.1-12.88-13.29225.04-20-2-6.7-2.51-1223
Tax %-13.443.33-0.98-24.69-119.27-39.92-9.5555.01-44.4834.06-5.36-1.1365.22-660-11.4938.25-2-3
Net Profit 7.85-5.89-23.32-9.7612.06-16.24-29.93-15.02-19.67-13.54-12.19-13.1478.28-19-3-5.93-3.47-1123
Net Profit Growth % (QoQ)233.3%74.7%-138.9%-180.9%174.3%45.7%-99.3%23.6%-45.3%-11.1%7.2%-116.8%512%-533.3%49.4%-70.9%68.5%-147.8%-
Net Profit Growth % (YoY)-34.9%63.7%22.1%35%161.3%-19.9%-145.5%-14.3%-125.1%28.7%-306.3%-121.6%2355.9%-72.7%-113%----
TTM Net Profit-31.12-26.91-37.26-43.87-49.13-80.86-78.16-60.42-58.5439.4133.9543.1450.35-31.4-23.42.68.53120
EPS in Rs5.680.41-5.25-1.617.47-3.04-6.81-2.71-4.63-2.91-3.22-3.3619.63-7.98-2.42-2.84-2.48-5.99.51
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
Sales73478874798284562318272997277826332603269230623547
Sales Growth %-6.9%5.5%-23.9%16.2%35.6%-65.9%-39%7.9%5.5%1.2%-3.3%-12.1%-13.7%-2.6%
Expenses68974370892578457217822827261724432396250628193159
Operating Profit44453957605145170161190207186243387
OPM %665678266787811
Other Income261216237444525459297107-87924-8
Interest728282606976174283249176151236217167
Depreciation204645383946239378416177164191141148
Profit before tax-21-71-72196-4-25-114-433-207-56-194-232-9163
Tax %-19-21-18743-55-135-442-58-72530
Net Profit -17-56-5950-4-11-99-453-199-80-82-216-11444
Net Profit Growth %69.6%5.1%-218%1350%63.6%88.9%78.1%-127.6%-148.8%2.4%62%-89.5%-359.1%-
EPS in Rs0.73-12.23-14.126.39-5.35-8.95-43.97-193.28-85.43-35.91-36.04-91.76-48.1416.81
Dividend Payout %00000000000000
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
Cash from Operating Activity1288562-7417225620698300177-315314227
Cash from Investing Activity-681-10636-421309-104-203-129-358247-351-966
Cash from Financing Activity-132-16936-19-55-83-1600-10391-15514911948661
Net Cash Flow-10-3-710-18-9-35-1-1316-325012-78
Balance Sheet
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
Equity Capital24242424242424242424242424242424
Reserves173430445452474507526385-93376590689107313001302
Borrowings6206726827397566396906777072270208920142122231121462104
Other Liabilities26255266329314424362300297888913830786933899971
Total Liabilities843138014171543156815931127106411123087340234573620434043684400
Fixed Assets433930949971103810454654945342005218024032432192621261493
CWIP87411110079170149161218262846
Investments14141112820000101000
Other Assets387429453559521545661570577100310519041026219619792061
Total Assets843138014171543156815931127106411123087340234573620434043684400
Delivery
#Date
52
33%
68
Value (Cr)Q/T
58
Del
74
Del
0
122-Jul61
0
85810
221-Jul61
0
41630
320-Jul62
0
29750
417-Jul61
0
27720
516-Jul63
0
71820
615-Jul63
0
31740
714-Jul64
0
43920
813-Jul64
0
47570
910-Jul63
0
77650
109-Jul65
0
68790
118-Jul62
0
34640
127-Jul62
0
36750
136-Jul63
0
59530
143-Jul60
0
41660
152-Jul61
0
21830
161-Jul61
0
23490
1730-Jun62
0
37510
1829-Jun56
0
58830
1925-Jun57
0
75970
2024-Jun56
0
15890
2123-Jun57
0
47990
2222-Jun57
0
23750
2319-Jun58
0
23770
2418-Jun56
0
64790
2517-Jun58
0
91980
2616-Jun57
0
44910
2715-Jun59
0
57840
2812-Jun60
0
85670
2911-Jun60
0
39930
3010-Jun62
0
44930
319-Jun63
0
51840
328-Jun63
0
22760
335-Jun64
0
105640
344-Jun63
0
25760
353-Jun64
0
74690
362-Jun66
0
51700
371-Jun64
0
59560
3829-May62
0
34990
3927-May62
0
19990
4026-May62
0
24740
4125-May62
0
29940
4222-May64
0
20990
4321-May63
0
10930
4420-May63
0
25800
4519-May64
0
16900
4618-May64
0
22690
4715-May65
0
65790
4814-May64
0
26710
Daily Market Cap
DateTotal Market CapChangeChg %
23-Jul141c1c0.81
22-Jul143c6c3.89
21-Jul148c4c2.77
17-Jul144c4c2.70
16-Jul148c24L0.16
15-Jul148c3c1.72
14-Jul151c00
13-Jul151c2L0.02
10-Jul151c5c2.87
09-Jul155c7c4.65
08-Jul148c1c0.71
07-Jul149c3c1.77
06-Jul147c4c2.62
02-Jul143c7c4.39
30-Jun150c17c12.61
29-Jun133c1c1.07
26-Jun134c5L0.04
25-Jun134c57L0.42
24-Jun134c61L0.46
23-Jun134c00
22-Jun134c2c1.72
19-Jun137c4c2.65
18-Jun133c4c2.59
17-Jun137c2c1.20
16-Jun135c4c2.83
15-Jun139c87L0.62
12-Jun140c73L0.52
11-Jun141c8c5.51
10-Jun149c00
Stock Checklist
Price is below from 52 week high low average: 28%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: YES
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: NO
Promoters are buying the stock: NO
Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
0